BRISBANE-based medical devices company Analytica has started producing its PeriCoach sensor devices, with first sales expected in the next few weeks.
The PeriCoach is an e-health treatment system for female Stress Urinary Incontinence, a condition that affects 1 in 3 women worldwide. It consists of a device, a web portal and a smartphone app.
The device evaluates activity in pelvic floor muscles, then transmits the information to a smartphone app, which uploads the information to the web portal where physicians can monitor patient progress.
This allows doctors to remotely determine if a woman is correctly performing pelvic floor exercises and if these are improving her condition.
The first units will be shipped to trained PeriCoach accredited pelvic floor exercise clinics and specialists, allowing patients of these clinics and specialists to purchase a device and subscription using dedicated point of sale hardware supplied by Analytica.
Analytica has slated 7400 devices to be delivered over the next few months in a Controlled Market Release phase, after which an iOS capable device will be ready. Sales of the initial production order at $298 per unit could provide $2.1m in revenue.
According to the company, it has designed the production system to be quickly and inexpensively scalable. Although the manufacturing partner for the devices can only make 125,000 units per annum, doubling the capacity would only cost $60,000 in duplicate tools, and take 8 weeks. Analytica expects production capacity increases will be funded from sales.
Analytica claims that if need be, it can increase production capacity to millions of units per annum for less than $1 million, while maintaining ownership of the tools and intellectual property.